It may be hypothesized on the basis of the current findings that similar neuroprotection against postoperative delirium in hip fracture could possibly be achieved by the use of NK1 receptor/substance P antagonist agents in the early postoperative phase. This evidence concerns the gene TAC1 and hip fracture.